Moshav Beit Gamliel, Israel

Ester Yoles

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 24(Granted Patents)


Location History:

  • Nahal Sorek, IL (2004)
  • D.N. Nahal Sorek, IL (2008)
  • Moshav Beit Gamliel, IL (2014 - 2016)
  • Rehovot, IL (2016)
  • Nahal Soreq, IL (2019)
  • Beit-Gamliel, IL (2021 - 2023)

Company Filing History:


Years Active: 2004-2023

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Ester Yoles: Innovator in Neurodegenerative Disease Treatment

Introduction

Ester Yoles is a prominent inventor based in Moshav Beit Gamliel, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of therapies for neurodegenerative diseases. With a total of eight patents to her name, Yoles has established herself as a key figure in medical innovation.

Latest Patents

Among her latest patents is a groundbreaking invention involving modified anti-PD-L1 antibodies. These antibodies are designed to abolish Fc-related effector function while enhancing the clearance rate, all while maintaining therapeutic efficacy for neurodegenerative disease modification. The patent also includes nucleic acid sequences and expression constructs that encode these modified antibodies, along with methods for their production. Furthermore, the specification outlines treatment methods that ensure the antibodies are present in the body for a specific duration, allowing for effective treatment while ensuring they are cleared adequately to maintain efficacy.

Career Highlights

Ester Yoles has worked with notable organizations such as Yeda Research and Development Co. Ltd. and Immunobrain Checkpoint, Inc. Her work in these companies has contributed to advancements in therapeutic strategies for complex diseases.

Collaborations

Yoles has collaborated with esteemed colleagues, including Michal Eisenbach-Schwartz and Ehud Hauben. These partnerships have fostered innovation and have been instrumental in her research endeavors.

Conclusion

Ester Yoles is a distinguished inventor whose work in modified anti-PD-L1 antibodies represents a significant advancement in the treatment of neurodegenerative diseases. Her contributions continue to impact the field of biotechnology and medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…